New Survey Data Reveals Prior Authorization or Other Utilization Management Strategies, Eligibility Requirements, Annual Maximum as Leading Cost Control Methods A new survey report from the International Foundation of Employee Benefit Plans reveals updated Canadian employer coverage and cost-control mechanisms surrounding glucagon-like […]
New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]
New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Has Increased to Almost Nine Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage surrounding glucagon-like peptide-1 (GLP-1) […]
